386
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Theoretical evaluation of the impact of diverse treatment conditions by calculation of the tumor control probability (TCP) of simulated cervical cancer Hyperthermia-Radiotherapy (HT-RT) treatments in-silico

, , , , , , & show all
Article: 2320852 | Received 26 Oct 2023, Accepted 15 Feb 2024, Published online: 11 Mar 2024
 

Abstract

Introduction

Hyperthermia (HT) induces various cellular biological processes, such as repair impairment and direct HT cell killing. In this context, in-silico biophysical models that translate deviations in the treatment conditions into clinical outcome variations may be used to study the extent of such processes and their influence on combined hyperthermia plus radiotherapy (HT + RT) treatments under varying conditions.

Methods

An extended linear-quadratic model calibrated for SiHa and HeLa cell lines (cervical cancer) was used to theoretically study the impact of varying HT treatment conditions on radiosensitization and direct HT cell killing effect. Simulated patients were generated to compute the Tumor Control Probability (TCP) under different HT conditions (number of HT sessions, temperature and time interval), which were randomly selected within margins based on reported patient data.

Results

Under the studied conditions, model-based simulations suggested a treatment improvement with a total CEM43 thermal dose of approximately 10 min. Additionally, for a given thermal dose, TCP increased with the number of HT sessions. Furthermore, in the simulations, we showed that the TCP dependence on the temperature/time interval is more correlated with the mean value than with the minimum/maximum value and that comparing the treatment outcome with the mean temperature can be an excellent strategy for studying the time interval effect.

Conclusion

The use of thermoradiobiological models allows us to theoretically study the impact of varying thermal conditions on HT + RT treatment outcomes. This approach can be used to optimize HT treatments, design clinical trials, and interpret patient data.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Data availability statement

The methods described in this manuscript were implemented in Python (version 3.9.7), and plots were created using R (version 4.1.3). All the codes used for simulating and plotting the presented results are available in the GitHub repository at https://github.com/mingzhaw/TCP_paper.git

Additional information

Funding

This project (Hyperboost; www.Hyperboost-h2020.eu (accessed on 10 November 2021)) has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 955625.